908 devices director Christopher Brown sells $169,800 in shares

Christopher D. Brown, a director of 908 Devices Inc., divested 20,000 shares of the company's stock on August 5, 2026, generating revenue of $169,800. This transaction, carried out under a pre-established Rule 10b5-1 trading strategy adopted in November 2025, involved multiple sales occurring at prices between $8.35 and $8.595 per share.

After this sale, Brown still owns 823,359 shares of 908 Devices Inc. The stock has since increased to $10.01, marking a substantial gain from the sale price. Analysis from InvestingPro indicates that MASS is trading above its fair value, with shares up more than 90% year-to-date. The stock is near its 52-week high of $10.52 and demonstrates strong momentum across various timeframes.

Pro Research Report offers detailed insights into MASS’s valuation and performance for investors interested in the full scope. Meanwhile, 908 Devices reported impressive second-quarter 2026 revenue, which grew by 23% from the prior year, reaching $16.1 million, exceeding Wall Street's estimate of $15.22 million. Despite this revenue growth, the company reported an adjusted loss per share of $0.32, which exceeded the estimated loss of $0.15.

Following the earnings release, 908 Devices raised its full-year sales guidance. Stifel responded to this positive news by raising its price target for 908 Devices shares from $10.00 to $12.00, while maintaining a Buy rating. This upward revision is attributed to favorable government policies and priorities impacting the company.